Digital JP Morgan Week 2025 – Phil Johnson Phil Johnson chat about why he joined Evidation and his excitement about the company’s mission.
Digital How do HCPs view the potential of AI in the pharmaceutical i... “AI has arrived,” British Prime Minister Keir Starmer declared in a recent speech.
Digital Simulated clinical trial populations and AI scalability AI might still be in the modish buzzword stage, but discussions exploring the potential for its scaling within life sciences are critical.
Digital Key trends shaping pharmaceutical operations in 2025 2025 will be a challenging year for many sectors with multiple headwinds, and the pharmaceutical industry is no exception.
Digital JP Morgan Week 2025 – Trân Lê and Sohit Gatiganti pharmaphorum sits down for a quick chat with the Grove.AI team about their new AI agent for clinical trial recruitment.
Digital Trust by design: Crafting authentic connections through digi... The pharmaceutical industry has long struggled to earn and sustain trust.
Oncology ESMO26: Taiho Oncology on improving the lives of patients wi... Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
